| Literature DB >> 12690653 |
Scott R Plotkin1, Patrick Y Wen.
Abstract
Neurologic complications of chemotherapy are relatively common. The diagnosis of chemotherapy-associated neurotoxicity remains a clinical one, and is largely based on the exclusion of other possible causes. The goal of this review is to describe the neurotoxicity associated with established chemothrerapeutic agents and with some of the newer biologic agents, monoclonal antibodies and targeted molecular therapies used in the treatment of cancer.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12690653 DOI： 10.1016/s0733-8619(02)00034-8
Source DB: PubMed Journal: Neurol Clin ISSN： 0733-8619 Impact factor: 3.806